Patients with B-cell non-Hodgkin Lymphoma scheduled to received CAR-T cell product according to Agenzia Italiana del Farmaco (AIFA) indications and technical data sheet of the drug
Availability of a 18F-FDG PET/CT scan or a full dose CT scan (without contrast media) pre-treatment with CART